94634 ⎘
Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Sub-classes:AZOBENZENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THERAPEUTIC TREATMENT ASSOCIATED WITH IONIZING RADIATIONS
#2METHODS FOR PREPARING PSMA CONJUGATES
#3Process Or The Preparation Of A Gadolinium Contrast Agent
#4USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#5USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#6NOVEL PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELANT 2,2',2''-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRA AZACYCLODODECANE- 1,4,7-TRIYL) TRIACETIC ACID AND IT’S COMPLEXES WITH PARAMAGNETIC METAL IONS
#7GADOLINIUM-BASED COMPOUND, AND MRI CONTRAST AGENT INCLUDING SAME
#8METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
#9SYNTHESIZING AN ORGANIC HIGH EXPLOSIVE IN A FLOW REACTOR
#10LIPIDS FOR NUCLEIC ACID DELIVERY
#11BICYCLIC HETEROCYCLES AND THEIR LIGANDS FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS
#12A METHOD OF PRODUCING EXPLOSIVE HMX BY FLOW SYNETHESIS
#13PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER
#14IONIZABLE LIPIDS AND COMPOSITIONS COMPRISING SAME
#15PROCESS TO PRODUCE HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE AND OCTAHYDRO-1,3,5,7-TETRANITRO-1,3,5,7-TETRAZOCINE WITH DIRECT RECYCLE OF SPENT ACID
#16GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING
#17EGFRVIII-TARGETED COMPOUNDS AND USES THEREOF
#18USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#19LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#20PRE-TARGETING STRATEGIES FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY
#21PROCESS FOR PRODUCING HEXAHYDRO 1,3,5-TRINITRO-1,3,5-TRIAZINE AND OCTAHYDRO-1,3,5,7-TETRANITRO-1,3,5,7-TETRAZOCINE
#22DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY
#23MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES
#24USE OF IMMUNE MODULATORS TO IMPROVE NERVE REGENERATION
#25BIFUNCTIONAL CHELATORS AND CONJUGATES
#26PROCESS FOR PRODUCING HEXAHYDRO 1,3,5-TRINITRO-1,3,5-TRIAZINE AND OCTAHYDRO-1,3,5,7-TETRANITRO-1,3,5,7-TETRAZOCINE
#27BIODEGRADABLE LIPIDS AND FORMULATIONS FOR INTRAMUSCULAR, IN VITRO, AND EX VIVO TRANSFECTION OF MRNA
#28NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING
#29COMPOUND AND RADIOACTIVE LABELING COMPOUND
#30PROCESS FOR PRODUCING HEXAHYDRO 1,3,5-TRINITRO-1,3,5-TRIAZINE AND OCTAHYDRO-1,3,5,7-TETRANITRO-1,3,5,7-TETRAZOCINE
#31METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF
#32Compound targeting prostate specific membrane antigen, and preparation method and application thereof
#33Bifunctional chelators and conjugates
#34Bifunctional chelators and conjugates
#35SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS
#36RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN
#37SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS
#38FUMARATE DERIVATIVES AND THEIR MEDICAL USE
#39COMPOUNDS AND METHODS TO TARGET GLUCOSE-STIMULATED PHOSPHOHISTIDINE SIGNALING AND ESOPHAGEAL CANCER GROWTH
#40Manufacturing process for preparing gadoteridol
#41TETRAAZADODECANE BASED CHELATING AGENTS FOR SEPARATION OF RARE EARTH ELEMENTS AND METHOD THEREFOR
#42PSMA-TARGETING COMPOUNDS AND USES THEREOF
#43COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME
#44COMPOUNDS FOR USE IN DIAGNOSIS AND/OR MONITORING OF FIBROSIS
#45PROCEDURE FOR OBTAINING GADOTERATE MEGLUMINE FROM HIGH-PURITY TETRAXETAN (DOTA) AND ITS USE IN THE PREPARATION OF INJECTABLE GALENICAL FORMULATIONS
#46NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR TREATING OR PREVENTING NEURAL DAMAGE, NEURAL DISEASE, OR DEVELOPMENTAL DISORDER THROUGH PROMOTING PROLIFERATION, DIFFERENTIATION, AND/OR REGENERATION OF NEURAL CELLS
#47BRANCHED DISCRETE PEG CONSTRUCTS
#48PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY
#49RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN
#50NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING
#51Manufacturing of protected DO3A
#52PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER
#53A DOTA binding chimeric antigen receptor for cellular therapy
#54SMALL MOLECULE INHIBITORS OF THE MCL-1 ONCOPROTEIN AND USES THEROF
#55METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX
#56PSMA-targeting compounds and uses thereof
#57METHOD FOR PRODUCING RADIOACTIVE METAL COMPLEX
#58METHODS FOR PREPARING PSMA CONJUGATES
#59Bifunctional do2pa derivatives, chelates with metallic cations and use thereof
#60METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
#61NOVEL AZOBENZENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THERAPEUTIC TREATMENT ASSOCIATED WITH IONIZING RADIATIONS
#62PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF
#63PSMA targeted fluorescent agents for image guided surgery
#64NOVEL TUMOR ANTIGEN BINDING AGENTS AND USES THEREOF
#65NOVEL PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELANT 2,2',2''-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRA AZACYCLODODECANE-1,4,7-TRIYL) TRIACETIC ACID AND IT'S COMPLEXES WITH PARAMAGNETIC METAL IONS
#66Radiolabeled compounds targeting the prostate-specific membrane antigen
#67Method for manufacturing calteridol
#68Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer
#69Chiral cyclen compounds and their uses
#70METHOD FOR MANUFACTURING CALCOBUTROL
#71CONJUGATED LIPOMERS AND USES THEREOF
#72HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING
#73DOTA COMPOUNDS AND USES THEREOF
#74Hydrolysis method for tert-butyl ester in gadolinium-based contrast agent
#75Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
#76Modified antibody and radioactive metal-labelled antibody
#77Compound, antiinflammatory drug comprising the compound and cyclooxygenase-2 inhibitor comprising the compound
#78Dimeric contrast agents
#79Use of immune modulators to improve nerve regeneration
#80METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF
#81Method for producing the crystalline form of modification a of calcobutrol
#82Method for producing calcobutrol
#83Gadolinium chelate compounds for use in magnetic resonance imaging
#84Method for preparing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
#85DIMERIC CONTRAST AGENTS
#86Contrast agents
#87Branched Discrete PEG Constructs
#88PSMA ligands for imaging and endoradiotherapy
#89METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
#90High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
#91Sensors for detection of negatively charged phosphate-containing membranes and membrane components
#92Lipophilic macrocyclic ligands, complexes thereof, and uses of same
#93PSMA targeted fluorescent agents for image guided surgery
#94Gadobutrol intermediate and gadobutrol production method using same
#95Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer
#96CATALYSTS
#97PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
#98Bifunctional do2pa derivatives, chelates with metallic cations and use thereof
#9920-HETE receptor (GPR75) antagonists and methods of use
#100Dimeric contrast agents
#101Multifunctional chelators, complexes, and compositions thereof, and methods of using same
#102Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
#103Dimeric contrast agents
#104LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#105Method for producing the crystalline form of modification a of calcobutrol
#106Contrast agents
#107Conjugated lipomers and uses thereof
#108LIBRARIES OF DIVERSE MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#109Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy
#110Pre-targeting strategies for molecular imaging and/or radioimmunotherapy
#111Energetic compounds and compositions
#112Gadolinium chelate compounds for use in magnetic resonance imaging
#113Methods to mobilize tissue resident cells for adoptive t cell therapy
#114Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
#115Catalysts
#116Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
#117Pharmacokinetic enhancements of bifunctional chelates and uses thereof
#118Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
#119DOTA synthesis
#120Dimeric contrast agents
#121Contrast agents
#122Method for preparing anti-heart-failure medicine LCZ696
#123Peptide thiourea derivative, radioisotope labeled compound containing same, and pharmaceutical composition containing same as active ingredient for treating or diagnosing prostate cancer
#124Process for the preparation of xylene linked cyclam compounds
#125Small molecule inhibitors of the MCL-1 oncoprotein and uses thereof
#126Gadolinium chelate compounds for use in magnetic resonance imaging
#127Substituted polycationic multi-quaternary ammonium salts as antimicrobial agents
#128Preparation of high-purity gadobutrol
#129Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
#130PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
#131Method for preparing gadobutrol
#132Targeted contrast agents comprising a hydrazide functional group
#133BIFUNCTIONAL do2pa DERIVATIVES, CHELATES WITH METALLIC CATIONS AND USE THEREOF
#134Branched discrete PEG constructs
#135PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
#136Metal complex formulations
#137Method for preparing calcobutrol
#1381,4,7,10-tetrazacyclododecane based agents to target bacteria and its use
#139Energetic compounds and compositions
#140Catalysts
#141Macrocyclic complexes, their process of preparation and use as PET imaging agents
#142Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
#143N-alkoxyamide conjugates as imaging agents
#144Process for purifying 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetraacetic acid
#145Gadolinium complex comprising DO3A-tranexamic acid conjugate
#146Excimer forming compounds
#147Multifunctional chelators, complexes, and compositions thereof, and methods of using same
#148LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER
#149Conjugated lipomers and uses thereof
#150Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency
#151Process for the preparation of macrocyclic polyazacarboxylate ligands and chelates
#152N-alkoxyamide conjugates as imaging agents
#153Preparation of Grignard reagents using a fluidized bed
#154Process for producing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid and complexes thereof
#155Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications
#156Compositions and methods for in vivo imaging
#157Macrocyclic Compositions And Metal Complexes For Bioimaging And Biomedical Applications
#158Process for the preparation of macrocyclic polyazacarboxylate ligands and chelates
#159Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
#160PSMA-targeting compounds and uses thereof
#161N-alkoxyamide conjugates as imaging agents
#162Method to Produce and Scale-Up Cocrystals and Salts Via Resonant Acoustic Mixing
#163Radiolabeled prostate specific membrane antigen inhibitors
#164N-alkoxyamide conjugates as imaging agents
#165Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof
#166Macrocyclic compounds for modulating IL-17
#167Process for the purification of polyaminocarboxylates
#168Methods for preparing functional tetraazacycloalkane compounds using a specific cyclic bisaminal compound
#169Aza metal complexes
#170CXCR4 inhibiting carriers for nucleic acid delivery
#171Macrocyclic compounds and metal complexes for bioimaging and biomedical applications
#172Responsive luminescent lathanide complexes
#173Preparation of high-purity gadobutrol
#174N-alkoxyamide conjugates as imaging agents
#175MRI contrast agent having gadolinium complex
#176Phosphorescent meso-unsubstituted metallo-tetrabenzoporphyrin probe molecules for measuring oxygen and imaging methods
#177Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency
#178Lipomacrocycles and uses thereof
#179Branched Discreet PEG Constructs
#180Radiolabeled prostate specific membrane antigen inhibitors
#181Polyazamacrocyclic compound, and a production method and a biomedical use therefor
#182N-alkoxyamide conjugates as imaging agents
#183METHODS AND COMPOSITIONS FOR COMPLEX BINDING OF METAL IONS
#184Process for the preparation of calcobutrol
#185Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof
#186Metal complexes of tetraazamacrocycle derivatives
#187Bifunctional polyazamacrocyclic chelating agents
#188Conjugated lipomers and uses thereof
#189Lubricant composition, fluorine-based compound, and use thereof
#190Tetraaza macrocyclic compound, preparation method thereof and use thereof
#191Method for separation of HMX and RDX
#192Complex compound and MRI probe made of same
#193HETEROCYCLE-AMINO ACID DERIVATIVES FOR TARGETING CANCER TISSUE AND RADIOACTIVE OR NON-RADIOACTIVE LABELED COMPOUNDS THEREOF
#194PSMA-targeting compounds and uses thereof
#195Materials and their use for the electrocatalytic evolution or uptake of H
#196Responsive luminescent lanthanide complexes
#197Intravascular contrast agents
#198Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging
#199CYLIC POLYAMINES FOR BINDING PHOSPHATIDYLSERINE
#200Complex Compound and MRI Probe Made of Same
#201Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents
#202Use of polymerizable macrocyclic polyethers and macrocyclic heteroanalogous polyethers in dental materials
#203COMPOUNDS COMPRISING PARAMAGNETIC CHELATES ARRANGED AROUND A CENTRAL CORE AND THEIR USE IN MAGNETO RESONANCE IMAGING AND SPECTROSCOPY
#204AZA compounds and production method thereof, and metal complexes as MRI contrast agents
#205Organic Compounds and their uses
#206Method of dynamic nuclear polarisation (DNP) and compounds and compositions for use in the method
#207Arene connected polyamine macrocyclic derivatives, preparation methods and pharmaceutical uses thereof
#208Macrocyclic compounds for inhibition of tumor necrosis factor alpha
#209Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
#210COMPOUNDS FOR THE DIAGNOSIS OF APOPTOSIS
#211Chelating Agent
#212Poly-Halo Metal X-ray Contrast Agents
#213Detection of cancer cells in vitro using sigma-2 receptor ligands as radiotracers
#214Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use
#215Peptide turn mimetics
#216N-alkoxyamide conjugates as imaging agents
#217MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS
#218Synthesis of cyclen derivatives
#219Bifunctional polyazamacrocyclic chelating agents
#220Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
#221Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
#222GLYCEROL ESTER DERIVATIVE HAVING METAL CHELATE STRUCTURE
#223Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
#224Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
#225Metal complexes of tetraazamacrocycle derivatives
#226Chemokine receptor modulators
#227CXCR4 antagonists
#228PI-3 kinase inhibitor prodrugs
#229Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use
#230Chelating agents with lipophilic carriers
#231Compounds Useful as Metal Chelators
#232Bifunctional chelators for sequestering lanthanides
#233Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
#234Compound for molecular electronic device
#235Polyamine compounds
#236Multivalent chelators containing a scaffold structure for modifying and organizing of target molecules
#237Optically pure and enriched isomers of chelating ligands and contrast agents
#238Targeted MR imaging agents
#239Polyamine-substituted ligands for use as contrast agents
#240Perfluoroalkyl-containing complexes, process for their production as well as their use
#241Macrocyclic oligonucleotide labeling reactants and conjugates derived thereof
#242Chelate based scaffolds in tumor targeting
#243Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates
#244Chemokine receptor binding heterocyclic compounds
#245Perfluoroalkyl-containing complexes, process for their production as well as their use
#246Hydrazide conjugates as imaging agents
#247Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
#248Detection of analytes in aqueous environments
#249Chemical exchange saturation transfer contrast agents
#250Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
#251Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylene, cyclene and functionalised cyclenes
#252Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same
#253Optically pure and enriched isomers of chelating ligands and contrast agents
#254Trimeric, macrocyclically substituted halo-benzene derivatives
#255Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives
#2561,4,7,10-Tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them
#25716-member ring metal chelate
#258Chemokine receptor binding heterocyclic compounds
#259Paramagnetic complexes with pendant crown compounds showing improved targeting-specificity as MRI contrast agents
#260Ammonium salts of inositol hexaphosphate, and uses thereof
#261Histogranin-like peptides, processes for their preparation and uses thereof
#262PI-3 kinase inhibitor prodrugs
#263Methods to modulate conditions mediated by the CXCR4 receptor
#264Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
#265Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis
#266Cyclic polyamine compounds for cancer therapy
#267Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
#268Polyamine compounds for treating chemokine receptor mediated diseases
#269Synthesis of tris N-alkylated 1,4,7,10-tetraazacyclododecanes